God-fearing, honest, ethical, and mission driven small family producer delivers impossible 21st Century Digital Medical Information Technology solution to save mankind!

The Tip of the spear of the 21st Century Digital Medical Information Technology Revolution: The Multifunction Computational Systems Engineering Diagnotic Electrophysiology Information Technology

In this age of the legacy of the backward analog, most dreaded, and badly broken “19th Century American Medicine Kabuki Dance Theater”, full of corruption, misinformation, disinformation, conspiracy, censorships, and plundering, a fearless small family business has stood up against ALL ODDS! In reality, only 1% of the medical devices, including us, a proud small family-owned&operated producer, and 6% of the drugs have reliable evidence to support the claims of safety and efficacy. These are invariably delivered only by honest and god-fearing small family-owned producers; Premier Heart’s Multifunction Cardiogram (M.C.G.) We dedicated the Technology to Delivering the Best Outcomes at the Lowest Costs. They are driving Substantial Savings in Proactive Early Detection and Ushering the Lifestyle-optimization into Mainstream Medicine and 100% Empirical, Evidence-Based, Highest Quality Standard, Primary Disease Prevention Payment Models: a 21st Century Scalable Digital tool based on Computational Electrophysiology Systems Engineering Designs. The Technology has received domestic and internationally FDA-Clearance. It delivers the highest possible diagnostic accuracy, both qualitatively and quantitatively. It also provides the earliest possible stage of cardiovascular disease detection, monitoring, and objective outcomes measurements to assist caregivers at the bedside in making the best decisions in less than 10 minutes.

The M.C.G. is an objective, accurate, non-invasive, and cost-effective 21st Century Digital Medicine tool that tells you a patient’s cardiovascular state in less than 10 minutes, literally ANYWHERE with Internet access! It is the world’s first entirely quantitative and objective solution for analyzing the unprecedented, extremely complex physiological interactions between the heart muscles and the blood supplies to analyze the entire cardiovascular system. It uses proprietary digital signal processing techniques to enable machine learning/deep neural network learning, i.e., A.I., with a digital platform verified and validated empirically internally and externally through independent third parties. We have explicitly adopted labeled training datasets from large, diverse populations of patients for objective algorithmic development. The training datasets consist of people from ages 14 to 100 split evenly across sexes. In addition, we have strategically procured data from various critical populations with diverse ethnicities and a stratum of geographies. We insisted on accepting the final definitive diagnosis strictly and objectively. The final diagnosis must come directly from gold and platinum standard tools; these include coronary angiography, fractional flow reserve or F.F.R., and classical and functional syntax scores. The arduous process provides the most accurate results in the industry. We have also learned that this meticulous training datasets procurement work has been the most intellectually challenging, time-consuming, low-yield (majority, 90+% data are either incomplete, untrustworthy, or poor quality), error-prone, labor-intense, and the most uncertain/the riskiest” bottleneck” aspect of the creative process building our technology platform.

The M.C.G. has proven its ability to detect ANY cause that contributes to abnormal cardiovascular system electrophysiology beyond ALL the current conventional stress imaging tools available ANYWHERE can provide. In addition, independent investigators have done extensive phase III/IV clinical validations and due diligence to determine that the M.C.G. is 3-5 times more accurate than the traditional E.C.G. and 2-3 times more accurate than the stress imaging tests.

But, how does M.C.G. technology allow for the avoidance of expensive cardiac testing?

Our solution’s unique capability is to detect the early stages of heart diseases and provide timely early warning of undetected or suspected heart attacks and heart failures; both are prominent indications of sudden cardiac death. These issues are fortunately easily reversible at this stage of diagnosis, thereby preventing catastrophic events that save lives and dramatically lessen the financial impact upon patients, their families, and businesses. Highmark Medicare independently assigned a DEVASTATING DISRUPTIVE (cardiology ball-busting) billable rate of $275 per test session per quarter four times a year. Furthermore, to protect the Medicare Trust Fund, these brave and ethical Highmark Medicare Medical Directors also stipulated that: “anyone tested on M.C.G., (making this decision based on the evidence of our technology’s superior meritorious diagnostic accuracies and savings from $25,000 to $50,000 per patient) Highmark shall not reimburse all the stress imaging tests, such as stress EKG, Echo, and Nuclear, in addition to the C.T.T. Angiogram” This fateful policy decision led to an ugly firestorm erupting from the A.C.C. member cardiologists. Attempts to sink or destroy us (including but MOT limited to throwing their kitchen sink at us!) by the corrupt “Alphabet Professional Medical Societies.”

It has NOT been pleasant. At times, we truly feared for our lives! Nevertheless, thanks to the love and support of my family, friends, employees, neighbors, investors, business partners, patients, supporters, and happy paying customers worldwide, we have miraculously survived their assault and continue to thrive! This craziness took some time to subside. Perhaps this is caused by 80% of cardiologists abandoning their once-lucrative private practices? Regardless, our customers, physicians, nurses, physician assistants, and especially their patients love our “magic-like” near rapid real-time reporting. They have determined that both are more accurate and detailed than any conventional testing modality without the need for stress, invasive exposure to radiation, IV contrast chemical dyes, drugs, or costly and risky means of diagnosis. These expensive late-stage-sickness-seeking tests are mainly reserved for patients with late-stage, severe signs of coronary artery disease and can afford to waste tens of thousands of dollars to obtain them. Our Technology can help people to avoid the usual pitfalls of questionable values and dubious outcomes that come with relying solely on expert opinion-based tests and treatments with the help of the objectivity of the technology’s 100% empirical evidence-based analytical capabilities.

This objectivity also extends to the treatment of women, who die with higher frequency than men from cardiovascular disorders, such as “Syndrome X” or “Micro-vascular” coronary/metabolic heart disease, left undetected and underdiagnosed for lack of better diagnostic tools. Our system has a training-datasets with a fair split between both sexes. We have intensively vetted the training datasets for developing the highest possible quality deep machine neural network learning algorithms. We designed the system to deliver much earlier disease detection with the highest possible sensitivity and specificity, thus the highest possible diagnostic accuracy. The diagnosticians can finally break away from the late-stage sickness-seeking profiteering legacy practice,” a reactionary strategy that dominates the legacy medical industry. They can provide the diagnosis at the most incredible speed, cost-efficiently, and non-invasively, causing zero external stress to the patient at the bedside to serve much larger potential patient populations. The testing session requires only 8 minutes. The report appears quickly to anyone that has a stable internet connection. Caregiver groups can help prevent patients from sudden cardiac death with much greater efficacy and speed than previously thought possible, optimizing the diagnostic workflow. One can imagine how useful this will be: for care teams to tackle chest pain patients presenting to the E.R. - by taking advantage of our Technology’s ability to quickly detect and identify patients who genuinely need admission to a hospital for acute care. Alternatively, physicians can safely send them home within an hour. The follow-up care will include plans to receive M.C.G. Technology monitored lifestyle optimization primary prevention to reduce or reverse their metabolic heart disease, or see a cardiologist for longer-term testing and treatment, only if necessary.

How is an M.C.G. test performed?

We apply five electrical leads on a patient, one on each ankle and wrist (Lead II), and the single fifth lead V5 on the left side of the chest. Once connected, the patient lies flat and still for approximately eight minutes while the M.C.G. device gathers electromechanical data on the entire cardiovascular system. There is 100% resting, non-invasive, and no physical or chemical stress, radiation, or intravenous contrast exposures are required. The report displays a disease severity score from zero (no cardiovascular disease present) to 22 (urgent care needed immediately for those scored 15-22); on a logarithmic scale, with 26 additional pathologic and physiopathologic conditions, the care team members can easily interpret.

What can M.C.G. Technology Help?

1) Early detection: screening enabling meaningful lifestyle optimization, primary heart disease prevention, and TIMELY reversal to deliver the best outcomes at the lowest cost possible

2) Better Diagnosis for ALL cardiovascular diseases, known or unknown

3) Better Evidence-Based Decision-Making for the best outcomes at the lowest cost

4) Validating Individualized Treatment Options for the best results

5) Painless, informative, and Comforting End-of-life care

6) Research: 100% Evidence-based Biomedical research, old or new drug discoveries, rediscoveries, old or new drugs, surgical or diagnostic procedures, objective and efficient trustworthy validation studies

7) Training: The greater accuracy of the device means that in academic settings, the device can be used as a new baseline to train students and provide vital information on all forms of scientific research.

8) Explore the impact of space travel, deep-sea diving, and high-altitude mountaineering on the cardiovascular system with more accurate detail.

What does it cost to perform M.C.G. testing, and how do you obtain the machine?

Costs vary based on economies of scale via the number of tests purchased. Although the M.C.G. Technology system is available for purchase through multiple financing options, please do not hesitate to contact Premier Heart, L.L.C., to discuss the optimal deployment approach for proposal quotes!

Please contact: Premier Heart Sales Team

Sales@PremierHeart.com P: 516-883-3383 M: 516-603-6368

Premier Heart, L.L.C. (Multifunction Cardiogram Technology Manufacturer/Developer)